Group 1 - The core theme of the 2026 CES is "AI deeply integrated into life," showcasing the global attention on health technology, with the company Beike (stock code: 688793) presenting its innovative "Technology × Traditional Chinese Medicine" achievements and global strategy [1] - Beike's globalization journey began with a strategic entry point, opening its first overseas store at Singapore Changi Airport in November 2024, establishing a high-standard brand image and testing operational logic for overseas markets [2] - The company has successfully implemented a replicable and efficient "brand store dealership model" in Thailand, which has led to profitability in Singapore and Malaysia, marking a sustainable development phase and providing stable cash flow for regional expansion [2] Group 2 - As of December 2025, Beike has established a global retail network with 125 standard direct stores, 77 global franchise stores, and over 500 other sales points, creating a comprehensive layout for brand experience and localized service [3] - The introduction of the "Relaxation Moment" sales-service integrated store model has become a second growth engine, combining sales of technology products with massage services, thus transforming the company's identity from a hardware provider to a personalized health solution service provider [3] - The CES participation is a significant milestone for Beike's globalization strategy, showcasing its product strength and brand ambition, with two flagship products addressing global consumer health pain points [4] Group 3 - The management expressed confidence in the company's global leadership ambitions, highlighting the successful validation of the "Technology × Traditional Chinese Medicine" concept in Southeast Asia and the systematic operational capabilities demonstrated through their expansion efforts [6] - Analysts note three core advantages of Beike's globalization path: clear strategy and strong execution, validated profitability models in Singapore and Malaysia, and significant differentiation through the "Technology × Traditional Chinese Medicine" concept [6] - The CES exhibition is expected to enhance the company's brand valuation as a global health technology brand, injecting strong momentum for long-term growth [6]

Core Insights - The article highlights the participation of Chinese health technology leader Beike (stock code: 688793) at the 2026 International Consumer Electronics Show (CES), showcasing its innovative products and global brand strategy [1][5]. Group 1: Product Launch and Innovation - Beike unveiled two flagship products, the AIR3 smart massage device and the See 7R eye care device, emphasizing the integration of AI technology in health solutions [4]. - The AIR3 smart massage device features a unique 5-second quick storage system and AI algorithms for personalized support, redefining travel comfort with its multifunctional capabilities [4]. - The See 7R eye massage device addresses dry eye syndrome through a three-step bionic therapy model, combining advanced technology with professional care techniques [4]. Group 2: Strategic Global Expansion - Beike's presence at CES is a significant step in its global strategy, following its successful market entry in Southeast Asia, including Singapore and Malaysia, where it achieved profitability [5]. - The company plans to implement a "one country, one policy" strategy for market expansion, focusing on both direct sales and franchise models in various Southeast Asian countries [5]. - The CES participation serves as a global validation of Beike's "technology × traditional Chinese medicine" concept and signals its commitment to international growth [5][6]. Group 3: Market Trends and Future Outlook - Industry analysis suggests that Beike is well-positioned to capitalize on the dual trends of global health consumption and AI technology proliferation, with a clear global strategy and proven profitability model [7]. - The CES showcase not only demonstrates Beike's product and technological capabilities but also aims to enhance its brand valuation in the global health technology market [7]. - The ongoing CES event, which runs until January 9, is attracting attention from global partners, media, and consumers, accelerating Beike's journey in the health technology sector [7].

Core Viewpoint - The company, Beiliang, is expanding its health management brand "Lighter Moment" to address the shortcomings of traditional massage products and offline experience stores, aiming to meet users' needs for quick relaxation through an innovative service model that combines technology and traditional Chinese medicine [1][2]. Group 1: Company Overview - Beiliang has established 6 "Lighter Moment" stores across major cities such as Shenzhen, Guangzhou, and Xi'an as of June 30, 2025, indicating initial success of the store model [1][3]. - The company plans to create more "Lighter Moment" stores in the future, enhancing its market presence and global influence by integrating technology with service advantages [1][3]. Group 2: Service Model - The "Lighter Moment" brand utilizes a three-in-one service system that combines smart devices, manual techniques, and moxibustion therapy, aiming to provide a comprehensive health management solution that emphasizes technology empowerment, professional service, and immediate experience [2].

Core Viewpoint - The company, Beiliang (688793), is focusing on expanding its innovative health management brand "Qing Song Yi Ke," which combines smart devices, manual techniques, and traditional Chinese medicine to meet consumer demands for immediate relaxation and professional service [2][3]. Group 1: Business Model and Strategy - "Qing Song Yi Ke" aims to address the limitations of traditional massage products and offline stores by providing a comprehensive service system that integrates technology and traditional practices [2]. - As of June 30, 2025, the company has established six "Qing Song Yi Ke" stores across major cities like Shenzhen, Guangzhou, and Xi'an, with plans for further expansion based on market conditions [2]. Group 2: Financial Performance - In Q1 2025, the company reported a main revenue of 197 million yuan, a year-on-year decrease of 32.83%, and a net profit attributable to shareholders of -1.83 million yuan, down 111.74% [3]. - The company's debt ratio stands at 39.98%, with investment income of 479,200 yuan and financial expenses of 333,900 yuan, while maintaining a gross profit margin of 61.24% [3]. Group 3: Market Sentiment and Ratings - Over the past 90 days, six institutions have provided ratings for the stock, with one buy rating, four hold ratings, and one neutral rating [4]. - The stock has seen a net outflow of 17.63 million yuan in financing over the last three months, indicating a decrease in financing balance, while the short-selling balance has increased [5].